Glaucoma & Cataract · Patient & Surgeon Guide
White flakes on the lens.
Higher eye pressure.
A harder cataract operation.
Pseudoexfoliation syndrome is an age-related build-up of flaky protein material inside the eye. It causes no symptoms of its own, yet it is one of the commonest identifiable causes of glaucoma worldwide and it quietly weakens the fibres that hold the lens in place. Here is what it is, why it matters, and how surgeons plan around it.
at diagnosis
linked (2007)
risk (EMGT)
Section 01 — What It Is
A silent deposit
that shows up
on a routine exam.
Pseudoexfoliation syndrome (PXF, also called exfoliation syndrome, XFS) is usually spotted by an eye specialist, not noticed by the patient. After dilating the pupil, the doctor sees a grey-white, dandruff-like layer on the front of the lens, often in a characteristic target pattern: a central disc, a clear ring, and a peripheral band.
That material is an abnormal fibrillar protein produced by cells of the lens capsule, iris, ciliary body and trabecular meshwork. It is a disorder of the extracellular matrix, and it is not limited to the eye: the same fibrils have been found in skin, blood vessel walls and other organs, though the clinical significance of that systemic spread is still debated. The name comes from its resemblance to true exfoliation of the lens capsule seen in glassblowers exposed to intense infrared heat, a different condition.
Pseudoexfoliation syndrome is an age-related condition in which flaky protein material collects on the lens, iris, zonules and drainage meshwork of the eye. It is usually found in people over 60, often starts in one eye, and has no symptoms by itself. It matters for two reasons. First, it clogs the drainage angle and is a leading identifiable cause of secondary open-angle glaucoma, which tends to run higher pressures and progress faster. Second, it weakens the zonules and limits pupil dilation, so cataract surgery carries a higher risk of lens-support problems, and the implant can occasionally slip years later. There is no cure; management means lifelong pressure checks and careful surgical planning.
Section 02 — Interactive
The fibres holding
your lens in place.
The lens hangs behind the pupil on hundreds of fine zonular fibres attached around its equator. In pseudoexfoliation those fibres can become coated, stretched and brittle. Switch between the stages below to see why surgeons worry about lens stability.
Clinically, zonular weakness shows up as phacodonesis (a lens that visibly trembles when the eye moves), iridodonesis (a quivering iris), a shallow or uneven front chamber, or a lens that has shifted slightly off-centre. Often there are no visible signs at all until surgery begins, which is why surgeons treat every eye with PXF as potentially having weak zonules.
Section 03 — Who Gets It
Age, ancestry
and a gene called LOXL1.
PXF is rare before about 50 and becomes steadily more common with each decade after. It is found in every population studied, but prevalence varies widely between regions and ethnic groups, and it has long been noted to be especially common in Scandinavian populations.
In 2007 a genome-wide association study from Iceland and Sweden (Thorleifsson et al., Science) found common variants in the LOXL1 gene strongly associated with both exfoliation syndrome and exfoliation glaucoma. LOXL1 encodes an enzyme involved in cross-linking elastic fibres, which fits the picture of an extracellular-matrix disorder. The puzzle is that the risk variants are also very common in people who never develop PXF, and the direction of the risk allele even flips in some populations. Later large studies (Aung et al., 2017) added further susceptibility loci. The current view is that genes set the stage, while ageing and environmental factors, with latitude and ultraviolet exposure among those studied, help decide who develops it.
| Factor | What the evidence suggests |
|---|---|
| Age | Strongest risk factor; uncommon before 50, rising sharply after 60 |
| Genetics | LOXL1 variants strongly associated; further loci found since; not a simple inherited disease |
| Geography | Prevalence differs markedly between populations; high in Nordic countries but seen worldwide, including South Asia |
| One eye or two | Often clinically one-sided at first; the second eye may become involved over years |
Section 04 — Exfoliation Glaucoma
Why the pressure
climbs, and why it moves faster.
Flakes and liberated iris pigment wash into the drainage angle and accumulate in the trabecular meshwork, while the meshwork tissue itself also produces the material. Outflow falls and pressure rises. When the optic nerve starts to be damaged, the diagnosis becomes exfoliation (pseudoexfoliative) glaucoma.
Early Manifest Glaucoma Trial (Leske et al. 2003), rounded. Bars are scaled for comparison, not percentages. See References.
Compared with ordinary primary open-angle glaucoma, exfoliation glaucoma is typically described as presenting with higher pressures, wider day-to-day swings in pressure, more optic nerve damage at diagnosis, and a less reliable response to drops alone. In the Early Manifest Glaucoma Trial, exfoliation was one of the factors associated with faster visual field progression, roughly doubling the hazard.
Treatment follows the same ladder as other open-angle glaucoma: pressure-lowering drops, selective laser trabeculoplasty (which often works well at first in PXF, though the effect may wane), and filtering or minimally invasive surgery when needed. Because PXF can exist for years before pressure rises, a normal reading today is not a reason to stop monitoring.
Section 05 — Cataract Surgery
What changes in
the operating room
when PXF is present.
People with PXF are also prone to cataract, so surgery is common. The operation is still usually successful, but published series consistently report higher rates of complications such as zonular dialysis, posterior capsule rupture and vitreous loss than in eyes without PXF. Good outcomes come from recognising it in advance and planning for it.
Surgeons commonly use trypan blue to stain the anterior capsule when the red reflex is dim through a small pupil, making the capsulorhexis easier to see and control. A sizeable capsulorhexis also reduces the pull of anterior capsule contraction on already-weak zonules. These are standard tools of cataract surgery, not special PXF treatments, and the decisions belong to the operating surgeon. Agaaz manufactures some of these consumables, including viscoelastics and trypan blue capsule stain; for the physics of choosing a viscoelastic, see our cohesive vs dispersive OVD guide below.
Late in-the-bag dislocation. Because zonules can keep weakening, the entire capsular bag with the lens implant inside can slowly drop, sometimes many years after an uneventful operation. Pseudoexfoliation is the risk factor most consistently reported in case series of this complication (for example Jehan et al., 2001). It presents as new blur, a doubled image in one eye, or a visible lens edge, and is usually fixed by repositioning or exchanging the lens.
was published
drainage angle
this age
Section 06 — Putting It Together
From a routine check
to a planned operation.
A man attends for cloudy vision in his left eye. After drops, his left pupil dilates only partly and the doctor sees a grey-white target pattern on the lens. Eye pressure is mildly raised on that side, the optic nerve looks healthy, and the lens shows a faint tremor when he looks around.
He is diagnosed with pseudoexfoliation syndrome with a cataract and started on a pressure-lowering drop. His surgeon plans for a small pupil and weak zonules: a pupil expansion device and a capsular tension ring are kept ready, and a dispersive viscoelastic is used to protect the cornea. Surgery goes smoothly. He is told that his pressure checks continue for life, and to report any new blur or double image even years from now.
Section 07 — FAQ
Frequently asked questions
about pseudoexfoliation.
Pseudoexfoliation syndrome (PXF, also called exfoliation syndrome) is an age-related condition in which a white, flaky, protein-rich material builds up on structures inside the eye, most visibly on the front surface of the lens and the edge of the pupil. The same material also collects on the zonules that hold the lens in place and in the eye's drainage meshwork. It is usually found in people over 60, often in one eye first, and is typically discovered during a routine dilated eye examination because it causes no symptoms of its own.
No, but it is one of the strongest known risk factors for it. The flaky material and released pigment can clog the trabecular meshwork, raising eye pressure. When that pressure damages the optic nerve the condition is called pseudoexfoliation (or exfoliative) glaucoma. It is widely described as the most common identifiable cause of secondary open-angle glaucoma worldwide. It tends to run higher and more variable pressures than ordinary open-angle glaucoma, and in the Early Manifest Glaucoma Trial exfoliation was linked to faster progression. Anyone with PXF needs regular pressure and optic nerve checks, even if their pressure is currently normal.
The exact cause is not fully understood. It is a disorder of the extracellular matrix, the scaffolding between cells. Genetics play a major role: common variants in the LOXL1 gene were strongly associated with the condition in a 2007 genome-wide study, and CACNA1A variants were identified later. But these variants are also common in people who never develop it, so ageing and environmental factors such as latitude and sunlight exposure are thought to contribute. It is not caused by anything the patient did and it is not contagious.
Two reasons. First, the pupil often dilates poorly, giving the surgeon a smaller window to work through. Second, the zonules, the fine fibres that suspend the lens, are often weakened by the deposits, so the lens can wobble or the support can partly give way during surgery. Published series report higher rates of zonular dialysis, capsule rupture and vitreous loss than in eyes without PXF. Experienced surgeons plan for this with pupil expansion devices, capsular tension rings, dispersive viscoelastics and gentle techniques, and most PXF cataract operations still go well.
It can, although it is uncommon. Because the zonules can continue to weaken after surgery, the whole capsular bag holding the implant can slowly slip, sometimes many years later. This is called late in-the-bag IOL dislocation, and pseudoexfoliation is the risk factor most consistently reported for it. Symptoms include new blurring, double vision in one eye, or seeing the edge of the lens. It is usually treatable surgically by repositioning or exchanging the lens, so new visual symptoms after cataract surgery should be reported rather than ignored.
There is currently no treatment that removes the material or stops it forming, and no proven way to prevent it. Management focuses on its consequences: regular monitoring for raised pressure and glaucoma, treating glaucoma with drops, laser trabeculoplasty or surgery when needed, and careful planning of cataract surgery. Removing the cataract does not remove the syndrome, so pressure checks continue for life.
References & Evidence Base
Peer-reviewed
citations.
Continue Reading
Related guides
from Beyond Vision.
Start writing here...
Pseudoexfoliation Syndrome: The Flaky Deposit Behind Glaucoma & Riskier Cataract Surgery (2026 Guide)